Showing 1 - 1 results of 1 for search '"KEYNOTE-590 clinical"', query time: 0.55s Refine Results
  1. 1
    Cost-Effectiveness Analysis of Pembrolizumab Plus Chemotherapy vs. Chemotherapy Alone as First-Line Treatment in Patients With Esophageal Squamous Cell Carcinoma and PD-L1 CPS of 10 or More

    Cost-Effectiveness Analysis of Pembrolizumab Plus Chemotherapy vs. Chemotherapy Alone as First-Line Treatment in Patients With Esophageal Squamous Cell Carcinoma and PD-L1 CPS of 1... by Zhiwei Zheng, Jingrong Lin, Huide Zhu, Hongfu Cai

    Published 2022-06-01
    Subjects:
    Get full text
    Article

Search Tools: